Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 52 of 100
Health
Testosterone Makes Men Want Luxury Brands and Status Goods, Study Finds
By
Sy Mukherjee
Health
New York and Virginia Become the First States to Require Mental Health Education in Schools
By
Sy Mukherjee
Health
Could Drinking Lots of Coffee Really Help You Live Longer? Here Are the Facts
By
Sy Mukherjee
Health
Is There a Limit to How Long Humans Can Live? A New Study Suggests There Isn’t
By
Sy Mukherjee
Health
Brainstorm Health: Living Forever, Dermira FDA Approval, The Science of Coffee
By
Sy Mukherjee
Health
Scientists Say They’ve Made Progress on an Artificial Ovary to Help Cancer Patients. There’s a Catch
By
Sy Mukherjee
Health
The Crazy Story Behind Why California Just Banned Soda Taxes
By
Sy Mukherjee
Health
Brainstorm Health: Digital Privacy and the Opioid Crackdown, Novartis Share Buyback, California Soda Tax Ban
By
Sy Mukherjee
Health
Novartis Is Spinning Off Its Alcon Eye Care Business and Launching a $5 Billion Share Buyback
By
Sy Mukherjee
Health
This New Single Dose Flu Drug Could Be Coming to the U.S. Before the Next Flu Season
By
Sy Mukherjee
Health
This Company Made the First FDA Approved, Marijuana Based Drug. Here’s What It Wants to Do Next
By
Sy Mukherjee
Health
Brainstorm Health: GW Pharma’s Next Step, GE Health Unit Spinoff, Justice Kennedy Retirement and Abortion
By
Sy Mukherjee
Health
What You Should Know About These Nasty, Rash-Causing Sea Lice Reported in Florida Beaches
By
Sy Mukherjee
Health
The AARP, UnitedHealth, and Quest Diagnostics Are Pouring $75 Million Into Fighting Alzheimer’s and Dementia
By
Sy Mukherjee
Health
Brainstorm Health: AARP Alzheimer’s Venture, AbbVie Calico Deal, Right to Try Controversy
By
Sy Mukherjee